ADC Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of HER-2 Positive Advanced Solid Tumors(PRaG3.0)
Clinical trial NCT05115500 · UNKNOWN
Trial details
- NCT number
- NCT05115500
- Sponsor
- Second Affiliated Hospital of Soochow University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-01
- Primary completion
- 2024-10-31
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.